• TRK Inhibitor Continues to Show Multi-Cancer Effects

    1 month ago - By MedPageToday

    Patients with a variety of cancers - with a common thread of harboring tropomyosin receptor kinase fusion pathology - responded to treatment with larotrectinib , according to research presented at the American...
    Read more ...

     

  • Safety of psilocybin lays groundwork for research in treatment-resistant depression

    Safety of psilocybin lays groundwork for research in treatment-resistant depression

    1 month ago - By Healio

    A psilocybin formulation was well tolerated among healthy patients, which supports research into its use for treatment-resistant depression, according to data presented at the American Society of Clinical Psychopharmacology Annual Meeting.
    “During the past decade, there has been a renewed interest in psilocybin as a potential treatment for depressive symptoms, and a number of studies have been presented,” Hans Eriksson, MD, chief medical officer of COMPASS Pathways, said during a virtual presentation. “All of these studies have contained instruments to assess severity of
    Read more ...